Close Menu
    SUBMIT

    Volume 10, Issue 3 (Jul-Sep 2005)

    Molecular mechanisms of cancer cells survival (pages 309 to 318)

    R. Tsanev (Institute of Molecular Biology, Bulgarian Academy of Sciences, Sofia, Bulgaria)

    Good Scientific Practice. Part VIII. Being a peer reviewer – you like it, or you hate it? (pages 319 to 322)

    Ljiljana Vukovi-Deki (Institute for Oncology and Radiology of Serbia, Beograd, Serbia and Montenegro)

    Anthracycline pretreated patients who is who in the chemotherapy choice of relapsed breast cancer (pages 323 to 328)

    M. Dediu (Institute of Oncology Bucharest, Department of Medical Oncology, Bucharest, Romania), A. Alexandru, D. Median

    The response of urological tumours to immunotherapy (pages 329 to 336)

    I. Gkialas (Department of Urology, General Hospital of Athens G. Gennimatas, Athens, Greece), A. Kalantzis, M. Lykourinas

    Dose escalation of docetaxel and ifosfamide in patients with advanced breast cancer failing prior anthracyclines mature results of a phase I-II study (pages 337 to 346)

    C. Cosmas (Department of Medical Oncology-B, Metaxa Cancer Hospital, Piraeus, Greece), N. Tsavaris, N. Malamos, G. Tsakonas, A. Gassiamis, H. Skopelitis, G. Soukouli, A. Polyzos, N. Mylonakis, A. Karabelis

    Randomized phase II study of induction chemotherapy with gemcitabine plus cisplatin followed by sequential radiotherapy versus radiotherapy alone in patients with stage III non-small cell lung cancer (pages 347 to 355)

    S. Beslija (Institute for Oncology, Clinical Center of Sarajevo University, Sarajevo, Bosnia and Herzegovina), Z. Dizdarevi, J. Lomigori, H. Zuti, M. Musanovi, B. Mehi, A. Cardji, B. Paralija, N. Obrali

    Phase II study of gemcitabine plus 5-fluorouracil biologically modulated by folinic acid plus long-acting formulation of octreotide (LAR) in patients with advanced pancreatic cancer (pages 357 to 364)

    A. Polyzos (Medical Oncology Unit, Laikon General Hospital, Athens University School of Medicine, Athens, Greece), N. Tsavaris, I. Vafiadis, K. Polyzos, J. Griniatsos, E. Felekouras, N. I. Nikiteas, S. Halikias, G. Nikou

    Short-term preoperative radiotherapy in locally advanced rectal cancer does not increase postoperative complications and improves the rate of sphincter-preserving surgery (pages 365 to 370)

    D. P. Korkolis (First Department of Surgery, Hellenic Anticancer Institute, Saint Savvas Hospital, Athens, Greece), G. D. Plataniotis, E. Gondikakis, D. Xinopoulos, J. Tzorbatzoglou, J. Katsilieris, P. P. Vassilopoulos

    Stage IB2 cervical cancer brachytherapy followed by radical hysterectomy (pages 371 to 375)

    A. Mandi (Department of Gynecologic Oncology, Institute of Oncology Sremska Kamenica, Serbia and Montenegro), P. Novakovi, M. Erak, S. Vitorovi, D. Ziki, D. Ninci

    Percutaneous stent placement in malignant cases of superior vena cava syndrome (pages 377 to 380)

    N. Baltayiannis (Department of Thoracic Surgery, Metaxa Cancer Hospital, Piraeus, Greece), D. Magoulas, D. Anagnostopoulos, N. Bolanos, P. Sfyridis, E. Georgiannakis, P. Zografos, A. Kayia, E. Kayianni, K. Sotirakoglou, A. Chatzimichalis

    Therapy of aggressive fibromatosis is still an open question: a series of patients treated at a single institution (pages 381 to 384)

    D. Risti (Department of Clinical Oncology, Institute for Oncology Radiology of Serbia, Belgrade, Serbia and Montenegro), Z. Tomasevi

    The influence of steroid receptors status on disease outcome in early breast cancer patients treated with adjuvant cyclophosphamide, methotrexate and fluorouracil chemotherapy (pages 385 to 391)

    S. unjar (Department of Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia and Montenegro), I. Kei, Z. Nekovi-Konstantinovi, D. Gavrilovi, D. Nikoli-Vukosavljevi

    Adenomyoepithelioma of the breast a case report and literature review (pages 393 to 395)

    R. Tait (Cambridge Breast Unit, Addenbrookes Hospital, Cambridge University Hospital NHS Foundation Trust, UK), S. E. Pinder, I. O. Ellis, A. D. Purushotham

    B-cell lymphoma presenting with renal failure associated to spontaneous tumor lysis syndrome and urinary tract obstruction (pages 397 to 400)

    G. Naeije (Department of Intensive Care and Thoracic Oncology, Centre des Tumeurs de l’Universite Libre de Bruxelles, Bruxelles, Belgium), A. P. Meert, F. Deneft, N. Meuleman, J. P. Sculier

    Long-standing complete remission following mitomycin-Cvinblastine chemotherapy for cutaneous and lymph node metastases from breast cancer resistant to multiple chemotherapy and hormonal lines and extensive radiotherapy an unusual case (pages 401 to 403)

    M. E. Stein (Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel), M. M. Quigley, A. Gershuny, J. Zaidan, N. Siegelmann Danieli

    Cerebellar and multiple spinal hemangioblastomas and intraventricular meningioma managed with subtotal resection and external beam radiotherapy report of a case with literature review (pages 405 to 409)

    G. Aksu (Gulhane Military Faculty of Medicine, Department of Radiation Oncology, Ankara, Turkey), C. Ulutin, M. Fayda, M. Saynak

    Primary signet-ring cell carcinoma of the prostate (pages 411 to 413)

    T. Klimis (Department of Pathology, 3rd Hospital of Social Security Foundation, Athens, Greece), A. Margaritopoulou, P. Vlahos, N. Kokotas

    William Halsted (1852-1922) one of America’s greatest surgeons and the surgical treatment of breast cancer (pages 415 to 421)

    G. Androutsos (Institute of History of Medicine, University Claude Bernard, Lyon, France)